{"id":"W2083751586","doi":"10.15273/dmj.vol39no2.3738","title":"A Review of Novel Anticoagulants","year":2013,"lang":"en","type":"review","venue":"Dalhousie Medical Journal","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Rivaroxaban; Apixaban; Dabigatran; Medicine; Atrial fibrillation; Warfarin; Vitamin k; Anticoagulant; Venous thromboembolism; Intensive care medicine; Discovery and development of direct thrombin inhibitors; Stroke (engine); Cardiology; Internal medicine; Thrombosis; Thrombin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007707246,0.001101287,0.001936871,0.005955841,0.0004052352,0.001252742,0.001121761,0.001105271,0.008080236],"category_scores_gemma":[0.001737008,0.0003773545,0.001065111,0.005403365,0.0003648928,0.001810302,0.0006743023,0.001284611,0.002351341],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006662862,"about_ca_system_score_gemma":0.00205592,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001414907,"about_ca_topic_score_gemma":0.00227007,"domain_scores_codex":[0.9994525,0.00007801608,0.0001703917,0.00008142742,0.0001873916,0.00003017954],"domain_scores_gemma":[0.9991996,0.0003764534,0.0001507922,0.00001933019,0.0002052722,0.00004861227],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009134843,0.0001048953,0.0003728496,0.06463632,0.0002267003,0.0005995477,0.0001136467,0.0001915858,0.0009738639,0.001547802,0.04153764,0.8896037],"study_design_scores_gemma":[0.0000431252,0.0001275595,0.001718934,0.02099748,0.0005693705,0.005169142,0.000125371,0.00009267619,0.0003625822,0.001170524,0.9695873,0.00003587517],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001079245,0.9986834,0.00006018556,0.0002145238,0.0001869865,0.000007373487,0.0000269677,0.000004462689,0.0007081651],"genre_scores_gemma":[0.0004024184,0.9986933,0.0001846638,0.0001558559,0.0002240445,0.00000751613,0.00003785583,8.50103e-7,0.0002935605],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.008080236,"threshold_uncertainty_score":0.02703112,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1974751679081404,"score_gpt":0.4417680493821492,"score_spread":0.2442928814740088,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}